Gainers

  • ANI Pharmaceuticals ANIP shares rose 31.1% to $47.99 during Wednesday's pre-market session. The market value of their outstanding shares is at $837.6 million.
  • Sunshine Biopharma SBFM stock increased by 19.48% to $1.0. The company's market cap stands at $22.5 million.
  • Spruce Biosciences SPRB stock increased by 17.14% to $1.23. The company's market cap stands at $28.9 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Statera BioPharma STAB stock increased by 16.86% to $0.14. The company's market cap stands at $7.4 million.
  • Burning Rock Biotech BNR shares increased by 10.52% to $2.52. The market value of their outstanding shares is at $266.4 million. As per the news, the Q3 earnings report came out yesterday.
  • AirSculpt Technologies AIRS stock moved upwards by 9.71% to $3.39. The market value of their outstanding shares is at $190.4 million. The company's, Q3 earnings came out 4 days ago.

Losers

  • Aptinyx APTX stock declined by 34.9% to $0.21 during Wednesday's pre-market session. The company's market cap stands at $14.4 million.
  • NeuBase Therapeutics NBSE shares declined by 19.56% to $0.23. The market value of their outstanding shares is at $7.5 million.
  • Trevena TRVN stock fell 16.19% to $2.9. The market value of their outstanding shares is at $20.1 million.
  • Lucira Health LHDX shares fell 12.63% to $0.38. The market value of their outstanding shares is at $15.2 million. As per the press release, Q3 earnings came out 2 days ago.
  • Alzamend Neuro ALZN shares declined by 12.13% to $0.98. The market value of their outstanding shares is at $93.9 million.
  • BrainsWay BWAY shares declined by 10.32% to $2.87. The company's market cap stands at $47.4 million. As per the news, the Q3 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!